ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/9/article-pxxxiv.xmlNCCN News2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/9/article-pxxxiv.pdf2026-04-18NCCN Newshttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/9/article-p1091.xmlNCCN Guidelines Insights: Acute Lymphoblastic Leukemia, Version 1.20172026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/9/article-p1091.pdf2026-04-18NCCN Guidelines Insights: Acute Lymphoblastic Leukemia, Version 1.2017https://harbor.dev.pubfactory.com/view/journals/jnccn/15/9/article-p1085.xml EGFR Exon 19 Deletion in Pancreatic Adenocarcinoma Responds to Erlotinib, Followed by T790M-Mediated Resistance2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/9/article-p1085.pdf2026-04-18 EGFR Exon 19 Deletion in Pancreatic Adenocarcinoma Responds to Erlotinib, Followed by T790M-Mediated Resistancehttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/9/article-p1083.xmlYour Genes: Getting the Best Fit2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/9/article-p1083.pdf2026-04-18Your Genes: Getting the Best Fithttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/9/article-pxliii.xmlOncology Research Program2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/9/article-pxliii.pdf2026-04-18Oncology Research Programhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/9/article-p1131.xml“Standard Care” in Cancer Clinical Trials: An Analysis of Care Provided to Women in the Control Arms of Breast Cancer Clinical Trials2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/9/article-p1131.pdf2026-04-18“Standard Care” in Cancer Clinical Trials: An Analysis of Care Provided to Women in the Control Arms of Breast Cancer Clinical Trialshttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/9/article-p1111.xmlA Double-Blind, Randomized, Placebo-Controlled Trial of Panax Ginseng for Cancer-Related Fatigue in Patients With Advanced Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/9/article-p1111.pdf2026-04-18A Double-Blind, Randomized, Placebo-Controlled Trial of Panax Ginseng for Cancer-Related Fatigue in Patients With Advanced Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/9/article-p1122.xmlRisk of Febrile Neutropenia Associated With Select Myelosuppressive Chemotherapy Regimens in a Large Community-Based Oncology Practice2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/9/article-p1122.pdf2026-04-18Risk of Febrile Neutropenia Associated With Select Myelosuppressive Chemotherapy Regimens in a Large Community-Based Oncology Practicehttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/9/article-p1104.xmlA Randomized Controlled Trial of an Additional Funding Intervention to Improve Clinical Trial Enrollment2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/9/article-p1104.pdf2026-04-18A Randomized Controlled Trial of an Additional Funding Intervention to Improve Clinical Trial Enrollmenthttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/9/article-p1140.xmlSurvivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/9/article-p1140.pdf2026-04-18Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncologyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/9/article-p1171.xmlTrials and Tribulations for Adolescents and Young Adults with Cancer: Measuring the Impact of a Community-Based Program2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/9/article-p1171.pdf2026-04-18Trials and Tribulations for Adolescents and Young Adults with Cancer: Measuring the Impact of a Community-Based Programhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/9/article-p1165.xmlSurvivorship Care Planning: Why Is It Taking So Long?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/9/article-p1165.pdf2026-04-18Survivorship Care Planning: Why Is It Taking So Long?